 |
Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma |
|---|---|
| Trade Name | Oncolym |
| Orphan Indication | B-cell non-Hodgkin's lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 1998-11-27 00:00:00 |
| Sponsor | Peregrine Pharmaceuticals, Inc.;14272 Franklin Ave., Suite 100;Tustin, California, 92780 |
